Bonus BioGroup Ltd. (TASE:BONS) announced that it has signed an investment agreement with two foreign investors for the private placement of 9,464,000 common shares at a price of $0.153846 per share for gross proceeds of $1,456,000 on November 25, 2016. The company will also issue 47,622 shares for free, because of a difference in the currency conversion. The transaction is subject to the listing approval from the Tel-Aviv Stock Exchange. The shares will be subject to a lock up period of 180 days immediately after the closing.